H.C. Wainwright Reaffirms Corcept Therapeutics Incorporated (CORT)’s $145 Price Target, Maintains Buy Rating
H.C.
Posts Tagged ‘NASDAQ:CORT’
Why Corcept Therapeutics Incorporated (CORT) Crashed On Monday
We recently published a list of These 10 Stocks Already Sank in June.
Corcept Therapeutics Incorporated (CORT)’s Reports Promising Phase 3 Results for Ovarian Cancer Drug
Corcept Therapeutics Incorporated (NASDAQ:CORT) is making headlines after its Phase 3 ROSELLA trial showed relacorilant, combined with nab-paclitaxel, reduced disease progression...
11 Best Performing Healthcare Stocks to Buy Now
On April 15, CNBC reported that President Trump's healthcare-focused executive order brought in a win for the sector.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2025 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2025 Earnings Call Transcript May 5, 2025Corcept Therapeutics Incorporated reports earnings inline with expectations.
Billionaire Jim Simons’ RenTech’s 10 Small-Cap Stock Picks with Huge Upside Potential
Jim Simons was (and still is even after his death in May 2024) one of the biggest names – if not the biggest – in the hedge fund space.
15 Best Growth Stocks to Buy for the Next 3 Years
On April 29, Dan Ives of Wedbush Securities joined 'Power Lunch' on CNBC to discuss his outlook for the tech sector and expressed that tariffs aren't stopping the AI revolution...
11 Best Guru Stocks to Buy According to Wall Street Analysts
Wall Street seems to be breathing a little easier after the initial panic over President Trump’s tariffs earlier this month, but the rollercoaster is not over just yet.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2024 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2024 Earnings Call Transcript February 26, 2025Corcept Therapeutics Incorporated misses on earnings expectations.
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may...
12 Hot Stocks to Buy According to Analysts
While the stock market in the United States remained closed on January 20 for Martin Luther King, Jr.
15 Best Growth Stocks to Buy for the Next 5 Years
Kevin Mahn, President & CIO at Hennion & Walsh Asset Management, recently appeared on CNBC on January 6 to discuss the current market momentum and emphasize the need for investors...
Corcept Therapeutics Incorporated (CORT) Surged on Strong Results and Increased Guidance
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” third quarter 2024 investor letter.
10 Stocks That Will Make You Rich In 2025
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2024 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2024 Earnings Call Transcript October 30, 2024Corcept Therapeutics Incorporated beats earnings expectations.
Does Corcept Therapeutics (CORT) Have a Long Runway for Growth?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” second quarter 2024 investor letter.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2024 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2024 Earnings Call Transcript July 29, 2024Corcept Therapeutics Incorporated beats earnings expectations.
What Makes Corcept Therapeutics (CORT) a Good Investment Bet?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” first quarter 2024 investor letter. A copy of the letter can...
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript
Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.28, expectations were $0.25.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2023 Earnings Call Transcript
Operator: Good day. And welcome to the Corcept Therapeutics Conference Call. At this time, all participants are in a listen-only mode.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2023 Earnings Call Transcript
Operator: Good day. And welcome to the Corcept Therapeutics Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Corcept Therapeutics conference call.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Corcept Therapeutics Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund and Insider Trading News: Steven Cohen, Ray Dalio, Luxor Capital, Engine No. 1, Three Arrows Capital, LifeMD Inc (LFMD), Corcept Therapeutics Incorporated (CORT), and More
NEW YORK (Reuters) - Billionaire investors Steven Cohen and Ray Dalio have joined the cryptocurrency craze by putting cash to work and saying at a conference this week that bitcoin...
Hedge Fund and Insider Trading News: Dan Kamensky, Bill Ackman, Alan Howard, Paul Tudor Jones, Kyle Bass, Vail Resorts, Inc. (MTN), Corcept Therapeutics Incorporated (CORT), and More
On a summer Friday afternoon last year, hedge-fund manager Dan Kamensky broke bankruptcy laws.
Is CORT A Good Stock To Buy According To Hedge Funds?
In this article we will analyze whether Corcept Therapeutics Incorporated (NASDAQ:CORT) is a good investment right now by following the lead of some of the best investors in the...
Hedge Funds Have Never Been This Bullish On Corcept Therapeutics Incorporated (CORT)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Did Hedge Funds Make The Right Call On Corcept Therapeutics Incorporated (CORT) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Standing By Corcept Therapeutics Incorporated (CORT)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Were Hedge Funds Right About Corcept Therapeutics Incorporated (CORT)?
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds.
Hedge Funds Are Buying Corcept Therapeutics Incorporated (CORT)
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking.
Did Hedge Funds Drop The Ball On Corcept Therapeutics Incorporated (CORT) ?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Here is What Hedge Funds Think About Corcept Therapeutics Incorporated (CORT)
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter.
Is Corcept Therapeutics Incorporated (CORT) A Good Stock To Buy?
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Hedge Fund and Insider Trading News: Och-Ziff Capital Management, Cyrus Capital Partners, KKR Real Estate Finance Trust Inc (KREF), Extreme Networks, Inc (EXTR), and More
Billionaire Dan Och’s hedge fund is pennies away from raising a red flag at the New York Stock Exchange.
Hedge Fund and Insider Trading News: Paul Singer, Tide Point Capital, Tenzing Acquisition Corp. Units (TZACU), Corcept Therapeutics Incorporated (CORT), Pure Bioscience, Inc. (PURE), and More
Amos Genish, Telecom Italia SpA’s CEO, seems to have a message for hedge fund billionaire Paul Singer: “Blink, I dare you.” The veteran telecoms executive has had a turbulent...
Market Movers Today: Corcept Therapeutics Incorporated (CORT), Eyegate Pharmaceuticals Inc (EYEG), Arconic Inc (ARNC), and More
Shares of Corcept Therapeutics Inc.
13D Filing: Longitude Capital Partners, LLC and Corcept Therapeutics Inc (CORT)
You can access the original SEC filing by clicking here.
13D Filing: Longitude Capital Partners, Llc and Corcept Therapeutics Inc (NASDAQ:CORT)
You can access the original SEC filing by clicking here.
Should You Add Corcept Therapeutics Incorporated (CORT) To Your Portfolio?
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
Why Are These Stocks Advancing on Tuesday?
With the new year rapidly approaching and many investors actively positioning themselves for the end of the 2015 tax year, shares of Freeport-McMoRan Inc (NYSE:FCX), Chimerix ...
Corcept Therapeutics Incorporated (CORT): Are Hedge Funds Right About This Stock?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
These Insider Sales Could Indicate That The Bull Market Has Run Its Course
The International Monetary Fund recently reduced its 2015 global growth estimates to 3.1% from 3.3%, pointing to the low-price commodity environment and China’s economic slowdown...
Hedge Funds Are Betting On Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (NASDAQ:ANIK) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.
Assessing Raptor Pharmaceutical Corp. (RPTP)’s Agreement With HealthCare Royalty Partners
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) signed an agreement with HealthCare Royalty Partners.
